Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
a study on Inflammatory Bowel Disease
Ulcerative ColitisColitisUlcerColitis, UlcerativeRPC1063RPC0163 (Ozanimod)
Lead Scientist at UCSF
- Jonathan Terdiman
Dr. Jonathan P. Terdiman is a Professor of Clinical Medicine and Surgery at UCSF. He earned his undergraduate degree from Princeton University in 1985 and his medical degree from the Columbia University College of Physicians and Surgeons in 1989.